At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
02496 YZYBIO-B
Not Yet Opened 12-18 16:08:08
3.980
+0.190
+5.01%
High3.980
Low3.980
Vol7.00K
Open3.980
D1 Closing3.790
Amplitude0.00%
Mkt Cap771.52M
Tradable Cap441.78M
Total Shares193.85M
T/O27.86K
T/O Rate0.01%
Tradable Shares111.00M
P/B--
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Disclaimer: HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its absolute accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.
Sino Biopharm Unit Obtains China License for YZY Bio's Cancer Drug
Wuhan YZY Biopharma Co Ltd is a China-based company principally engaged in the research, development, production and sales of pharmaceuticals. The Company is mainly engaged in the research, development and industrialization of bispecific antibody drugs. The Company's main products include anti-PD1&anti-CD3, anti-CD19&anti-CD3, and anti-CDX&CD3. The Company's drug products are mainly used in major diseases such as tumor, immunity, inflammation, cardiovascular and infection.